IL1RL1 is dynamically expressed on Cbfb-MYH11 + leukemia stem cells and promotes cell survival

Yiqian Wang, Lisa Richter, Michelle Becker, Catalina Amador, Ricia K Hyde

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Acute myeloid leukemia (AML) is often characterized by the presence of specific, recurrent chromosomal abnormalities. One of the most common aberrations, inversion of chromosome 16 [inv(16)], generates the fusion oncogene CBFB-MYH11. Previously, we used a mouse knock-in model to show that Cbfb-MYH11 induces changes in gene expression and results in the accumulation of abnormal myeloid cells, a subset of which are enriched for leukemia stem cell (LSC) activity. One gene upregulated by Cbfb-MYH11 encodes the cytokine receptor IL1RL1 (ST2). IL1RL1 and its ligand IL-33 are known regulators of mature myeloid cells, but their roles in AML are not known. Here, we use Cbfb-MYH11 knock-in mice to show that IL1RL1 is expressed by cell populations with high LSC activity, and that the cell surface expression of IL1RL1 is dynamic, implying that the expression of IL1RL1 is not restricted to a specific stage of differentiation. We also show that treatment with IL-33 increased serial replating ability and expression of pro-survival proteins in vitro. Finally, we show that IL1RL1 + cells can survive chemotherapy better than IL1RL1 cells in vivo. Collectively, our results indicate that IL1RL1 is dynamically expressed in Cbfb-MYH11 + leukemia cells and promotes their survival.

Original languageEnglish (US)
Article number1729
JournalScientific Reports
Volume9
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

Cell Survival
Leukemia
Stem Cells
Myeloid Cells
Acute Myeloid Leukemia
Oncogene Fusion
Chromosomes, Human, Pair 16
Cytokine Receptors
Chromosome Aberrations
Ligands
Gene Expression
Drug Therapy
Population
Genes
Proteins
Interleukin-33
Therapeutics

ASJC Scopus subject areas

  • General

Cite this

IL1RL1 is dynamically expressed on Cbfb-MYH11 + leukemia stem cells and promotes cell survival . / Wang, Yiqian; Richter, Lisa; Becker, Michelle; Amador, Catalina; Hyde, Ricia K.

In: Scientific Reports, Vol. 9, No. 1, 1729, 01.12.2019.

Research output: Contribution to journalArticle

@article{c041bc49e3814a89bf674294706573d4,
title = "IL1RL1 is dynamically expressed on Cbfb-MYH11 + leukemia stem cells and promotes cell survival",
abstract = "Acute myeloid leukemia (AML) is often characterized by the presence of specific, recurrent chromosomal abnormalities. One of the most common aberrations, inversion of chromosome 16 [inv(16)], generates the fusion oncogene CBFB-MYH11. Previously, we used a mouse knock-in model to show that Cbfb-MYH11 induces changes in gene expression and results in the accumulation of abnormal myeloid cells, a subset of which are enriched for leukemia stem cell (LSC) activity. One gene upregulated by Cbfb-MYH11 encodes the cytokine receptor IL1RL1 (ST2). IL1RL1 and its ligand IL-33 are known regulators of mature myeloid cells, but their roles in AML are not known. Here, we use Cbfb-MYH11 knock-in mice to show that IL1RL1 is expressed by cell populations with high LSC activity, and that the cell surface expression of IL1RL1 is dynamic, implying that the expression of IL1RL1 is not restricted to a specific stage of differentiation. We also show that treatment with IL-33 increased serial replating ability and expression of pro-survival proteins in vitro. Finally, we show that IL1RL1 + cells can survive chemotherapy better than IL1RL1 − cells in vivo. Collectively, our results indicate that IL1RL1 is dynamically expressed in Cbfb-MYH11 + leukemia cells and promotes their survival.",
author = "Yiqian Wang and Lisa Richter and Michelle Becker and Catalina Amador and Hyde, {Ricia K}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-018-38408-3",
language = "English (US)",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - IL1RL1 is dynamically expressed on Cbfb-MYH11 + leukemia stem cells and promotes cell survival

AU - Wang, Yiqian

AU - Richter, Lisa

AU - Becker, Michelle

AU - Amador, Catalina

AU - Hyde, Ricia K

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Acute myeloid leukemia (AML) is often characterized by the presence of specific, recurrent chromosomal abnormalities. One of the most common aberrations, inversion of chromosome 16 [inv(16)], generates the fusion oncogene CBFB-MYH11. Previously, we used a mouse knock-in model to show that Cbfb-MYH11 induces changes in gene expression and results in the accumulation of abnormal myeloid cells, a subset of which are enriched for leukemia stem cell (LSC) activity. One gene upregulated by Cbfb-MYH11 encodes the cytokine receptor IL1RL1 (ST2). IL1RL1 and its ligand IL-33 are known regulators of mature myeloid cells, but their roles in AML are not known. Here, we use Cbfb-MYH11 knock-in mice to show that IL1RL1 is expressed by cell populations with high LSC activity, and that the cell surface expression of IL1RL1 is dynamic, implying that the expression of IL1RL1 is not restricted to a specific stage of differentiation. We also show that treatment with IL-33 increased serial replating ability and expression of pro-survival proteins in vitro. Finally, we show that IL1RL1 + cells can survive chemotherapy better than IL1RL1 − cells in vivo. Collectively, our results indicate that IL1RL1 is dynamically expressed in Cbfb-MYH11 + leukemia cells and promotes their survival.

AB - Acute myeloid leukemia (AML) is often characterized by the presence of specific, recurrent chromosomal abnormalities. One of the most common aberrations, inversion of chromosome 16 [inv(16)], generates the fusion oncogene CBFB-MYH11. Previously, we used a mouse knock-in model to show that Cbfb-MYH11 induces changes in gene expression and results in the accumulation of abnormal myeloid cells, a subset of which are enriched for leukemia stem cell (LSC) activity. One gene upregulated by Cbfb-MYH11 encodes the cytokine receptor IL1RL1 (ST2). IL1RL1 and its ligand IL-33 are known regulators of mature myeloid cells, but their roles in AML are not known. Here, we use Cbfb-MYH11 knock-in mice to show that IL1RL1 is expressed by cell populations with high LSC activity, and that the cell surface expression of IL1RL1 is dynamic, implying that the expression of IL1RL1 is not restricted to a specific stage of differentiation. We also show that treatment with IL-33 increased serial replating ability and expression of pro-survival proteins in vitro. Finally, we show that IL1RL1 + cells can survive chemotherapy better than IL1RL1 − cells in vivo. Collectively, our results indicate that IL1RL1 is dynamically expressed in Cbfb-MYH11 + leukemia cells and promotes their survival.

UR - http://www.scopus.com/inward/record.url?scp=85061267822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061267822&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-38408-3

DO - 10.1038/s41598-018-38408-3

M3 - Article

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 1729

ER -